PENTOXIFYLLINE
Clinical trials for PENTOXIFYLLINE explained in plain language.
Never miss a new study
Get alerted when new PENTOXIFYLLINE trials appear
Sign up with your email to follow new studies for PENTOXIFYLLINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common drug slow kidney disease? new study investigates
Disease control CompletedThis study tested whether pentoxifylline, a drug used for blood flow issues, can reduce inflammation and slow kidney disease in non-diabetic patients. 42 adults with moderate chronic kidney disease took either standard therapy alone or standard therapy plus pentoxifylline for 6 m…
Matched conditions: PENTOXIFYLLINE
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Drug may shield kidneys from dye harm in ICU
Prevention CompletedThis study tested whether pentoxifylline, a drug that improves blood flow, can prevent kidney damage caused by contrast dye used in medical imaging. The trial included 70 adults with chronic kidney disease who were in the intensive care unit and needed contrast dye. Researchers m…
Matched conditions: PENTOXIFYLLINE
Phase: NA • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC